1,422
views
0
recommends
+1 Recommend
3 collections
    0
    shares
       
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Acute inflammatory Transverse Myelitis post Pfizer-BioNTech-COVID-19 vaccine in 16-year-old

      Preprint
      research-article
      This is not the latest version for this article. If you want to read the latest version, click here.
      Bookmark

            Abstract

            Coronavirus disease 2019 (COVID-19) originated in China in early March 2019. Saudi Food and Drug Authorityapproved the registration of the Pfizer-BioNTech COVID-19 vaccine in Saudi Arabia on December 10, 2020 and on May 10, 2021, Pfizer-BioNTech was given an authorized emergency use in 12 to 15 years old children. Saudi Arabia’s Ministry of Health started Pfizer-BioNTech COVID-19 vaccination for 12 to 18 years old on June 27, 2021. Here we have a case of 16-year-old female admitted to the medical ward diagnosed with acute inflammatory transverse myelitis after two weeks from second dose of the Pfizer-BioNTech COVID-19 vaccine. The diagnosis was based on normal laboratory workup but significant radiological findings. She was discharged after a full recovery.There are multiple cases of post-vaccine acute inflammatory transverse myelitisshared by medical journals, but due to lack of literature review for the teenager population, we think our case may be the first case of acute inflammatory transverse myelitis following second dose of Pfizer-BioNTech COVID-19 vaccine in this population.

            Content

            Author and article information

            Journal
            ScienceOpen Preprints
            ScienceOpen
            11 October 2021
            Affiliations
            [1 ] Internal Medicine, Hera General Hospital, Makkah, Saudi Arabia
            [2 ] Public Health, Hera General Hospital, Makkah, Saudi Arabia
            Author notes
            Article
            10.14293/S2199-1006.1.SOR-.PPVXII5.v1
            b2422521-7440-4a0d-8a38-167cd824534d

            This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .


            All data generated or analysed during this study are included in this published article (and its supplementary information files).
            Neurology
            Transverse myelitis,Pfizer,Saudi Arabia,Teenager,complication,BioNTech, COVID-19, vaccination,Corona,COVID-19 vaccine

            Comments

            Comment on this article